Symbols / WINT $0.02 -4.17% Windtree Therapeutics, Inc.
WINT Chart
Stock Fundamentals
|
|
|
|
|
|
About
Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trials to treat respiratory distress syndrome in premature infants; Surfaxin, a lyophilized KL4 surfactant for the treatment of respiratory disease, disorder, or condition in humans; Rostafuroxin, which is in Phase 2b clinical trials for the treatment of genetically associated hypertension; and oral and intravenous SERCA2a activators, which are in preclinical trials for the treatment of chronic and acute heart failure. In addition, it is developing an aPKCi inhibitor, which is in preclinical trials for the treatment of cutaneous malignancies and solid tumors. Windtree Therapeutics, Inc. has a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sale of a portfolio of potential KL4 surfactant products; a license, development, and commercialization agreement with Lee's Pharmaceutical (HK) Ltd. and Zhaoke Pharmaceutical (Hefei) Co. Ltd.; a license agreement with Philip Morris USA, Inc. and Johnson & Johnson; and a collaboration with Battelle Memorial Institute for the development of its aerosol delivery system. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was founded in 1992 and is headquartered in Warrington, Pennsylvania.
Ratings
Current target
$0.02
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-12-04 | reit | HC Wainwright & Co. | Neutral → Neutral | $7 |
| 2024-01-03 | init | HC Wainwright & Co. | — → Neutral | $1 |
- AI mortgage marketplace CommLoan goes nationwide, pursues reverse merger - Stock Titan ue, 17 Mar 2026 07
- WINT | WINDTREE THERAPEUTICS NEW Insider Trading - Quiver Quantitative ue, 21 Apr 2026 08
- Why WINT Stock is Surging? - StocksToTrade Mon, 14 Jul 2025 07
- Windtree Therapeutics (WINT) signs LOI to acquire fintech lender CommLoan - Stock Titan Wed, 03 Dec 2025 08
- Nasdaq Boots Windtree a Month After $700M BNB Treasury Pivot Fails to Lift Stock - Yahoo Finance Wed, 20 Aug 2025 07
- Nasdaq to delist BNB token treasury company Windtree Therapeutics for noncompliance - The Block Wed, 20 Aug 2025 07
- BNB hits all-time high as Windtree faces Nasdaq delisting, WINT plunges - FXStreet hu, 21 Aug 2025 07
- Windtree Therapeutics to be delisted from Nasdaq, will trade over the counter - Investing.com Wed, 20 Aug 2025 07
- Heart failure drug lineup sold, but seller keeps a slice of future sales - Stock Titan ue, 23 Dec 2025 08
- Windtree Therapeutics Is Exploding On Trader TikTok – But Is WINT A Hidden Gem Or Just Hopium? - AD HOC NEWS hu, 01 Jan 2026 08
- Betting on BNB is futile! Windtree's stock price has been forced to delist due to long-term 'zero status' - Binance Wed, 20 Aug 2025 07
- WINT: Windtree Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits hu, 19 Jan 2017 00
- Windtree’s Stock Upsurge: Is Innovation the Key? - StocksToTrade hu, 03 Jul 2025 07
- Windtree Therapeutics issues $1.6 million in convertible notes due 2026 - Investing.com hu, 16 Oct 2025 07
- Windtree Therapeutics, Inc. Announces Reverse Stock Split - Yahoo Finance ue, 18 Feb 2025 08
Financials
Statement View
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
25.02
+42.65%
|
17.54
-19.87%
|
21.89
-32.15%
|
32.26
|
| Research And Development |
|
16.28
+95.13%
|
8.34
-24.85%
|
11.10
-37.60%
|
17.79
|
| Selling General And Administration |
|
8.74
-4.95%
|
9.20
-14.75%
|
10.79
-25.45%
|
14.47
|
| General And Administrative Expense |
|
8.74
-4.95%
|
9.20
-14.75%
|
10.79
-25.45%
|
14.47
|
| Other Gand A |
|
8.74
-4.95%
|
9.20
-14.75%
|
10.79
-25.45%
|
14.47
|
| Total Expenses |
|
25.02
+42.65%
|
17.54
-19.87%
|
21.89
-32.15%
|
32.26
|
| Operating Income |
|
-25.02
-42.65%
|
-17.54
+19.87%
|
-21.89
+32.15%
|
-32.26
|
| Total Operating Income As Reported |
|
-26.14
-26.91%
|
-20.60
+50.17%
|
-41.33
+46.52%
|
-77.28
|
| EBITDA |
|
-1.47
+92.69%
|
-20.16
+49.59%
|
-39.99
+48.28%
|
-77.32
|
| Normalized EBITDA |
|
-25.27
-47.79%
|
-17.10
+19.51%
|
-21.25
+34.22%
|
-32.30
|
| Reconciled Depreciation |
|
0.08
+2.44%
|
0.08
-84.62%
|
0.53
+177.60%
|
0.19
|
| EBIT |
|
-1.56
+92.30%
|
-20.24
+50.05%
|
-40.52
+47.72%
|
-77.51
|
| Total Unusual Items |
|
23.80
+878.25%
|
-3.06
+83.69%
|
-18.74
+58.37%
|
-45.02
|
| Total Unusual Items Excluding Goodwill |
|
23.80
+878.25%
|
-3.06
+83.69%
|
-18.74
+58.37%
|
-45.02
|
| Special Income Charges |
|
13.32
+535.48%
|
-3.06
+84.27%
|
-19.44
+56.81%
|
-45.02
|
| Other Special Charges |
|
-14.44
|
—
|
—
|
—
|
| Impairment Of Capital Assets |
|
1.12
-63.37%
|
3.06
-84.27%
|
19.44
-56.81%
|
45.02
|
| Net Income |
|
-1.79
+91.19%
|
-20.29
+48.25%
|
-39.21
+42.03%
|
-67.64
|
| Pretax Income |
|
-1.79
+91.16%
|
-20.29
+49.99%
|
-40.58
+47.73%
|
-77.62
|
| Net Non Operating Interest Income Expense |
|
-0.17
-160.00%
|
0.28
+391.07%
|
0.06
+343.48%
|
-0.02
|
| Interest Expense Non Operating |
|
0.23
+370.00%
|
0.05
-5.66%
|
0.05
-53.51%
|
0.11
|
| Net Interest Income |
|
-0.17
-160.00%
|
0.28
+391.07%
|
0.06
+343.48%
|
-0.02
|
| Interest Expense |
|
0.23
+370.00%
|
0.05
-5.66%
|
0.05
-53.51%
|
0.11
|
| Interest Income Non Operating |
|
0.07
-78.46%
|
0.33
+198.17%
|
0.11
+19.78%
|
0.09
|
| Interest Income |
|
0.07
-78.46%
|
0.33
+198.17%
|
0.11
+19.78%
|
0.09
|
| Other Income Expense |
|
23.39
+872.75%
|
-3.03
+83.85%
|
-18.74
+58.66%
|
-45.34
|
| Other Non Operating Income Expenses |
|
-0.41
-1416.13%
|
0.03
+1450.00%
|
0.00
+100.63%
|
-0.32
|
| Gain On Sale Of Security |
|
10.48
|
—
|
0.70
|
—
|
| Tax Provision |
|
-0.01
|
0.00
+100.00%
|
-1.37
+86.31%
|
-9.99
|
| Tax Rate For Calcs |
|
0.00
|
0.00
-100.00%
|
0.00
-73.81%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.08
|
0.00
+100.00%
|
-0.63
+89.10%
|
-5.79
|
| Net Income Including Noncontrolling Interests |
|
-1.79
+91.19%
|
-20.29
+48.25%
|
-39.21
+42.03%
|
-67.64
|
| Net Income From Continuing Operation Net Minority Interest |
|
-1.79
+91.19%
|
-20.29
+48.25%
|
-39.21
+42.03%
|
-67.64
|
| Net Income From Continuing And Discontinued Operation |
|
-1.79
+91.19%
|
-20.29
+48.25%
|
-39.21
+42.03%
|
-67.64
|
| Net Income Continuous Operations |
|
-1.79
+91.19%
|
-20.29
+48.25%
|
-39.21
+42.03%
|
-67.64
|
| Normalized Income |
|
-25.51
-48.01%
|
-17.23
+18.31%
|
-21.10
+25.74%
|
-28.41
|
| Net Income Common Stockholders |
|
-5.49
+72.96%
|
-20.29
+48.25%
|
-39.21
+42.03%
|
-67.64
|
| Diluted EPS |
|
-104.35
+97.79%
|
-4,718.84
+91.57%
|
-56,007.00
+48.00%
|
-107,700.64
|
| Basic EPS |
|
-104.35
+97.79%
|
-4,718.84
+89.67%
|
-45,696.97
+57.57%
|
-107,700.64
|
| Basic Average Shares |
|
0.05
+1122.86%
|
0.00
+401.17%
|
0.00
+36.62%
|
0.00
|
| Diluted Average Shares |
|
0.05
+1122.86%
|
0.00
+401.17%
|
0.00
+36.62%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-5.49
+72.96%
|
-20.29
+48.25%
|
-39.21
+42.03%
|
-67.64
|
| Preferred Stock Dividends |
|
3.70
|
—
|
—
|
—
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
27.88
-13.98%
|
32.41
-14.62%
|
37.95
-49.25%
|
74.79
|
| Current Assets |
|
2.57
-52.15%
|
5.38
-27.08%
|
7.38
-68.60%
|
23.49
|
| Cash Cash Equivalents And Short Term Investments |
|
1.78
-58.81%
|
4.32
-30.02%
|
6.17
-72.38%
|
22.35
|
| Cash And Cash Equivalents |
|
1.78
-58.81%
|
4.32
-30.02%
|
6.17
-72.38%
|
22.35
|
| Prepaid Assets |
|
—
|
—
|
—
|
1.14
|
| Other Current Assets |
|
0.80
-25.00%
|
1.06
-12.03%
|
1.21
+5.42%
|
1.14
|
| Total Non Current Assets |
|
25.30
-6.39%
|
27.03
-11.61%
|
30.58
-40.39%
|
51.30
|
| Net PPE |
|
1.16
-28.58%
|
1.63
-23.07%
|
2.12
-37.65%
|
3.39
|
| Gross PPE |
|
4.99
-7.10%
|
5.37
-7.02%
|
5.77
-42.97%
|
10.12
|
| Accumulated Depreciation |
|
-3.83
-2.25%
|
-3.74
-2.27%
|
-3.66
+45.65%
|
-6.73
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
1.27
+0.95%
|
1.26
-0.87%
|
1.27
-75.04%
|
5.09
|
| Other Properties |
|
1.05
-27.22%
|
1.44
-22.07%
|
1.85
-22.18%
|
2.38
|
| Leases |
|
2.66
+0.00%
|
2.66
+0.57%
|
2.65
+0.00%
|
2.65
|
| Goodwill And Other Intangible Assets |
|
24.13
-4.44%
|
25.25
-10.80%
|
28.31
-40.72%
|
47.75
|
| Goodwill |
|
—
|
0.00
-100.00%
|
3.06
-80.50%
|
15.68
|
| Other Intangible Assets |
|
24.13
-4.44%
|
25.25
+0.00%
|
25.25
-21.27%
|
32.07
|
| Other Non Current Assets |
|
0.01
-94.00%
|
0.15
-2.60%
|
0.15
+0.00%
|
0.15
|
| Total Liabilities Net Minority Interest |
|
17.88
-38.38%
|
29.02
+3.84%
|
27.94
-15.09%
|
32.91
|
| Current Liabilities |
|
5.72
+43.07%
|
4.00
+62.64%
|
2.46
-50.09%
|
4.92
|
| Payables And Accrued Expenses |
|
3.58
+47.71%
|
2.43
+34.76%
|
1.80
-56.08%
|
4.10
|
| Payables |
|
2.14
+164.52%
|
0.81
+224.90%
|
0.25
-64.07%
|
0.69
|
| Accounts Payable |
|
1.88
+132.26%
|
0.81
+224.90%
|
0.25
-64.07%
|
0.69
|
| Current Accrued Expenses |
|
1.45
-10.69%
|
1.62
+4.25%
|
1.55
-54.46%
|
3.41
|
| Total Tax Payable |
|
0.26
|
0.00
|
—
|
—
|
| Current Debt And Capital Lease Obligation |
|
1.17
+74.74%
|
0.67
+1.98%
|
0.66
-20.19%
|
0.82
|
| Current Debt |
|
0.66
+183.69%
|
0.23
-7.54%
|
0.25
-14.29%
|
0.29
|
| Other Current Borrowings |
|
0.33
+42.92%
|
0.23
-7.54%
|
0.25
-14.29%
|
0.29
|
| Current Capital Lease Obligation |
|
0.51
+16.51%
|
0.44
+7.92%
|
0.40
-23.48%
|
0.53
|
| Other Current Liabilities |
|
0.96
+7.00%
|
0.90
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
12.16
-51.39%
|
25.02
-1.83%
|
25.48
-8.93%
|
27.98
|
| Long Term Debt And Capital Lease Obligation |
|
0.65
-43.76%
|
1.16
-28.51%
|
1.62
-21.58%
|
2.07
|
| Long Term Capital Lease Obligation |
|
0.65
-43.76%
|
1.16
-28.51%
|
1.62
-21.58%
|
2.07
|
| Non Current Deferred Liabilities |
|
4.53
-10.48%
|
5.06
-0.06%
|
5.06
-28.86%
|
7.11
|
| Non Current Deferred Taxes Liabilities |
|
4.53
-10.48%
|
5.06
-0.06%
|
5.06
-28.86%
|
7.11
|
| Other Non Current Liabilities |
|
3.80
-79.79%
|
18.80
+0.00%
|
18.80
+0.00%
|
18.80
|
| Preferred Securities Outside Stock Equity |
|
3.18
|
0.00
|
0.00
|
0.00
|
| Stockholders Equity |
|
10.00
+194.78%
|
3.39
-66.13%
|
10.01
-76.09%
|
41.88
|
| Common Stock Equity |
|
10.00
+194.78%
|
3.39
-66.13%
|
10.01
-76.09%
|
41.88
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
0.26
+3748.65%
|
0.01
+676.46%
|
0.00
+36.62%
|
0.00
|
| Ordinary Shares Number |
|
0.26
+3748.63%
|
0.01
+676.46%
|
0.00
+36.62%
|
0.00
|
| Treasury Shares Number |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Additional Paid In Capital |
|
859.66
+0.99%
|
851.27
+1.63%
|
837.60
+0.88%
|
830.26
|
| Retained Earnings |
|
-846.61
-0.21%
|
-844.82
-2.46%
|
-824.53
-4.99%
|
-785.32
|
| Treasury Stock |
|
3.05
+0.00%
|
3.05
+0.00%
|
3.05
+0.00%
|
3.05
|
| Total Equity Gross Minority Interest |
|
10.00
+194.78%
|
3.39
-66.13%
|
10.01
-76.09%
|
41.88
|
| Total Capitalization |
|
10.00
+194.78%
|
3.39
-66.13%
|
10.01
-76.09%
|
41.88
|
| Working Capital |
|
-3.14
-327.26%
|
1.38
-71.89%
|
4.92
-73.50%
|
18.57
|
| Invested Capital |
|
10.66
+194.07%
|
3.62
-64.69%
|
10.26
-75.66%
|
42.17
|
| Total Debt |
|
1.82
-0.44%
|
1.83
-19.74%
|
2.28
-21.19%
|
2.89
|
| Capital Lease Obligations |
|
1.16
-27.30%
|
1.60
-21.25%
|
2.03
-21.97%
|
2.60
|
| Net Tangible Assets |
|
-14.13
+35.34%
|
-21.86
-19.47%
|
-18.30
-211.63%
|
-5.87
|
| Tangible Book Value |
|
-14.13
+35.34%
|
-21.86
-19.47%
|
-18.30
-211.63%
|
-5.87
|
| Current Notes Payable |
|
0.33
|
0.00
|
—
|
—
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-15.40
-14.62%
|
-13.44
+30.92%
|
-19.45
+17.80%
|
-23.66
|
| Cash Flow From Continuing Operating Activities |
|
-15.40
-14.62%
|
-13.44
+30.92%
|
-19.45
+17.80%
|
-23.66
|
| Net Income From Continuing Operations |
|
-1.79
+91.19%
|
-20.29
+48.25%
|
-39.21
+42.03%
|
-67.64
|
| Depreciation Amortization Depletion |
|
0.08
+2.44%
|
0.08
-84.62%
|
0.53
+177.60%
|
0.19
|
| Depreciation And Amortization |
|
0.08
+2.44%
|
0.08
-84.62%
|
0.53
+177.60%
|
0.19
|
| Other Non Cash Items |
|
8.68
+2022.49%
|
0.41
-22.54%
|
0.53
-54.91%
|
1.17
|
| Stock Based Compensation |
|
0.46
-64.40%
|
1.28
-58.59%
|
3.09
-57.36%
|
7.24
|
| Asset Impairment Charge |
|
1.12
-63.37%
|
3.06
-84.27%
|
19.44
-56.81%
|
45.02
|
| Deferred Tax |
|
-0.21
|
0.00
+100.00%
|
-1.37
+86.31%
|
-9.99
|
| Deferred Income Tax |
|
-0.21
|
0.00
+100.00%
|
-1.37
+86.31%
|
-9.99
|
| Operating Gains Losses |
|
-25.34
-281633.33%
|
0.01
+101.30%
|
-0.69
-274.49%
|
0.40
|
| Gain Loss On Investment Securities |
|
-10.56
|
—
|
—
|
—
|
| Unrealized Gain Loss On Investment Securities |
|
0.22
|
0.00
|
—
|
—
|
| Net Foreign Currency Exchange Gain Loss |
|
-0.34
-11166.67%
|
-0.00
+99.58%
|
-0.71
-279.29%
|
0.40
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.01
-36.84%
|
0.02
|
0.00
|
| Change In Working Capital |
|
1.37
-32.06%
|
2.02
+213.56%
|
-1.78
-2963.79%
|
-0.06
|
| Change In Prepaid Assets |
|
1.08
+16.79%
|
0.92
-14.22%
|
1.08
-21.17%
|
1.36
|
| Change In Payables And Accrued Expense |
|
1.27
+102.88%
|
0.63
+127.43%
|
-2.28
-160.80%
|
-0.88
|
| Change In Accrued Expense |
|
0.20
+203.03%
|
0.07
+103.59%
|
-1.84
-351.60%
|
-0.41
|
| Change In Payable |
|
1.07
+91.07%
|
0.56
+226.13%
|
-0.44
+5.13%
|
-0.47
|
| Change In Account Payable |
|
1.07
+91.07%
|
0.56
+226.13%
|
-0.44
+5.13%
|
-0.47
|
| Change In Other Current Liabilities |
|
-0.98
-308.32%
|
0.47
+182.14%
|
-0.57
-4.20%
|
-0.55
|
| Investing Cash Flow |
|
-0.01
+20.00%
|
-0.01
-107.61%
|
0.20
+170.61%
|
-0.28
|
| Cash Flow From Continuing Investing Activities |
|
-0.01
+20.00%
|
-0.01
-107.61%
|
0.20
+170.61%
|
-0.28
|
| Net PPE Purchase And Sale |
|
-0.01
+20.00%
|
-0.01
-107.61%
|
0.20
+170.61%
|
-0.28
|
| Purchase Of PPE |
|
-0.01
+20.00%
|
-0.01
-15.38%
|
-0.01
+95.34%
|
-0.28
|
| Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.21
|
0.00
|
| Capital Expenditure |
|
-0.01
+20.00%
|
-0.01
-15.38%
|
-0.01
+95.34%
|
-0.28
|
| Financing Cash Flow |
|
12.73
+9.81%
|
11.60
+276.58%
|
3.08
-89.51%
|
29.36
|
| Cash Flow From Continuing Financing Activities |
|
12.73
+9.81%
|
11.60
+276.58%
|
3.08
-89.51%
|
29.36
|
| Net Issuance Payments Of Debt |
|
1.26
+257.72%
|
-0.80
+32.11%
|
-1.17
+69.68%
|
-3.87
|
| Issuance Of Debt |
|
1.86
|
0.00
|
—
|
0.00
|
| Repayment Of Debt |
|
-0.60
+24.09%
|
-0.80
+32.11%
|
-1.17
+69.68%
|
-3.87
|
| Long Term Debt Issuance |
|
1.86
|
0.00
|
—
|
0.00
|
| Long Term Debt Payments |
|
-0.15
|
0.00
+100.00%
|
-1.17
+69.68%
|
-3.87
|
| Net Long Term Debt Issuance |
|
1.71
|
0.00
+100.00%
|
-1.17
+69.68%
|
-3.87
|
| Short Term Debt Payments |
|
-0.46
+42.91%
|
-0.80
+32.11%
|
-1.17
|
—
|
| Net Short Term Debt Issuance |
|
-0.46
+42.91%
|
-0.80
+32.11%
|
-1.17
|
—
|
| Net Common Stock Issuance |
|
5.49
-52.50%
|
11.55
+171.55%
|
4.25
-86.81%
|
32.23
|
| Cash Dividends Paid |
|
-0.66
|
0.00
|
—
|
—
|
| Repurchase Of Capital Stock |
|
-1.88
|
0.00
|
—
|
—
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
0.84
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
8.52
|
—
|
—
|
1.00
|
| Changes In Cash |
|
-2.68
-44.37%
|
-1.86
+88.52%
|
-16.18
-398.56%
|
5.42
|
| Beginning Cash Position |
|
4.47
-29.36%
|
6.33
-71.89%
|
22.50
+31.71%
|
17.08
|
| End Cash Position |
|
1.79
-59.99%
|
4.47
-29.36%
|
6.33
-71.89%
|
22.50
|
| Free Cash Flow |
|
-15.41
-14.59%
|
-13.45
+30.89%
|
-19.46
+18.70%
|
-23.94
|
| Common Stock Issuance |
|
5.49
-52.50%
|
11.55
+171.55%
|
4.25
-86.81%
|
32.23
|
| Issuance Of Capital Stock |
|
5.49
-52.50%
|
11.55
+171.55%
|
4.25
-86.81%
|
32.23
|
| Net Preferred Stock Issuance |
|
-1.88
|
0.00
|
—
|
—
|
| Preferred Stock Dividend Paid |
|
-0.66
|
0.00
|
—
|
—
|
| Preferred Stock Payments |
|
-1.88
|
0.00
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-01-07 View
- 8-K2025-12-02 View
- 10-Q2025-11-19 View
- 8-K2025-10-16 View
- 8-K2025-10-06 View
- 8-K2025-09-08 View
- 8-K2025-09-02 View
- 8-K2025-08-20 View
- 10-Q2025-08-19 View
- 8-K2025-08-08 View
- 8-K2025-08-05 View
- 8-K2025-08-04 View
- 8-K2025-07-24 View
- 8-K2025-07-17 View
- 8-K2025-07-03 View
- 8-K2025-06-27 View
- 8-K2025-06-20 View
- 8-K2025-06-11 View
- 8-K2025-05-16 View
- 10-Q2025-05-15 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|